A new trading day began on Friday, with Sana Biotechnology Inc (NASDAQ: SANA) stock price up 12.46% from the previous day of trading, before settling in for the closing price of $2.81. SANA’s price has ranged from $1.52 to $12.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 17.68%. With a float of $122.67 million, this company’s outstanding shares have now reached $223.11 million.
Let’s determine the extent of company efficiency that accounts for 328 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Sana Biotechnology Inc (SANA) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Sana Biotechnology Inc is 45.04%, while institutional ownership is 55.28%. The most recent insider transaction that took place on Jan 16 ’25, was worth 289,500. Before that another transaction happened on Jan 08 ’25, when Company’s See Remark 1 sold 290,912 for $6.49, making the entire transaction worth $1,887,320. This insider now owns 4,541,511 shares in total.
Sana Biotechnology Inc (SANA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.56% during the next five years compared to -83.13% drop over the previous five years of trading.
Sana Biotechnology Inc (NASDAQ: SANA) Trading Performance Indicators
Here are Sana Biotechnology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.41, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.87 in one year’s time.
Technical Analysis of Sana Biotechnology Inc (SANA)
Looking closely at Sana Biotechnology Inc (NASDAQ: SANA), its last 5-days average volume was 2.93 million, which is a drop from its year-to-date volume of 12.09 million. As of the previous 9 days, the stock’s Stochastic %D was 40.13%. Additionally, its Average True Range was 0.39.
During the past 100 days, Sana Biotechnology Inc’s (SANA) raw stochastic average was set at 28.37%, which indicates a significant decrease from 54.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 95.12% in the past 14 days, which was lower than the 181.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.64, while its 200-day Moving Average is $4.69. However, in the short run, Sana Biotechnology Inc’s stock first resistance to watch stands at $3.32. Second resistance stands at $3.47. The third major resistance level sits at $3.72. If the price goes on to break the first support level at $2.92, it is likely to go to the next support level at $2.67. Now, if the price goes above the second support level, the third support stands at $2.52.
Sana Biotechnology Inc (NASDAQ: SANA) Key Stats
With a market capitalization of 705.53 million, the company has a total of 223,269K Shares Outstanding. Currently, annual sales are 0 K while annual income is -283,260 K. The company’s previous quarter sales were 0 K while its latest quarter income was -59,920 K.
